Request for Covid-19 Impact Assessment of this Report
Market Segmentation:
By Type (Software, Services), End Users (Biotechnology & Pharmaceuticals, Contract Research Organizations (CROS), Hospitals, KPOs/BPOs, Healthcare Providers), Distribution Channel (Direct Sales, Retail Sales), Country (China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific)
Some of the major factors contributing to the growth of the market are:
• Increasing contract research organizations
• Improving healthcare infrastructure
Market Players:
The key market players for Asia-Pacific drug safety solutions and pharmacovigilance market are listed below:
• Pharmaceutical Product Development, LLC
• Drug Safety Solutions Limited
• C3i
• Worldwide Clinical Trials
• Bioclinica
• United Biosource LLC
• Ennov
• AB Cube
• Covance Inc.
• Accenture
• PRA Health Sciences, Inc.
• Ergomed
• IQVIA
• Genpact
• Cognizant
• Parexel International Corporation
• ArisGlobal
• ICON plc
• Oracle
• Syneos Health
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.10 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING NUMBER OF CLINICAL TRIALS
3.1.2 GROWING NUMBER OF CONTRACT RESEARCH ORGANIZATIONS
3.1.3 INCREASE IN R & D EXPENDITURE BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
3.1.4 INCREASE IN THE NUMBER OF ADVERSE DRUG REACTIONS (ADRS)
3.2 RESTRAINT
3.2.1 HIGH COST OF DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE
3.3 OPPORTUNITIES
3.3.1 AUTOMATION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE
3.3.2 RESEARCH COLLABORATIONS AND PARTNERSHIPS
3.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
3.4 CHALLENGE
3.4.1 THE MISREPORTING AND MISCODING OF ADVERSE EVENTS
4 EXECUTIVE SUMMARY
5 ASIA PACIFIC DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE
5.1 OVERVIEW
5.2 SOFTWARE
5.2.1 ADVERSE EVENT REPORTING SOFTWARE
5.2.1.1 ON-PREMISE
5.2.1.2 CLOUD BASED
5.2.2 DRUG SAFETY AUDITS SOFTWARE
5.2.2.1 ON-PREMISE
5.2.2.2 CLOUD BASED
5.2.3 DATA MANAGEMENT SOFTWARE
5.2.3.1 ON-PREMISE
5.2.3.2 CLOUD BASED
5.2.4 FULLY INTEGRATED SOFTWARE
5.2.4.1 ON-PREMISE
5.2.4.2 CLOUD BASED
5.2.5 ISSUE TRACKING SOFTWARE
5.2.5.1 ON-PREMISE
5.2.5.2 CLOUD BASED
5.2.6 CLINICAL TRIAL MANAGEMENT SOLUTION
5.2.6.1 ON-PREMISE
5.2.6.2 CLOUD BASED
5.2.7 REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE
5.2.7.1 ON-PREMISE
5.2.7.2 CLOUD BASED
5.2.8 MEDICAL AFFAIRS SOFTWARE
5.2.8.1 ON-PREMISE
5.2.8.2 CLOUD BASED
5.2.9 OTHERS
5.2.9.1 ON-PREMISE
5.2.9.2 CLOUD BASED
5.3 SERVICES
5.3.1 CLINICAL DATA MANAGEMENT
5.3.1.1 DATA ENTRY AND CASE PROCESSING
5.3.1.2 CLINICAL TRIAL MONITORING
5.3.1.3 CLINICAL TRIAL SAFETY SUBMISSIONS
5.3.1.4 CASE PROCESSING (SAES)
5.3.1.5 OTHERS
5.3.2 DRUG SAFETY SOLUTIONS
5.3.2.1 QUALITY AND MEDICAL REVIEW
5.3.2.2 LITERATURE AND SOCIAL MEDIA MONITORING
5.3.2.3 SAFETY DATABASE
5.3.2.4 INDIVIDUAL CASE STUDY REPORT
5.3.2.5 PERIODIC REPORTS
5.3.2.6 MEDICAL LITERATURE SEARCH
5.3.2.7 SIGNAL DETECTION
5.3.2.8 EXPEDITED REPORTS
5.3.2.9 OTHERS
5.3.3 AGGREGATE SAFETY REPORTING
5.3.4 REGULATORY SERVICES
5.3.4.1 SAFETY REGULATORY SUBMISSIONS
5.3.4.2 POST-MARKETING SURVEILLANCE
5.3.4.3 MEDICAL DEVICE VIGILANCE
5.3.4.4 REGULATORY CONSULTING
5.3.4.5 OTHERS
5.3.5 RISK MANAGEMENT SERVICES
5.3.6 MEDICAL INFORMATION CALL CENTER SERVICES
5.3.7 AUDIT SERVICES
5.3.8 TRAINING SUPPORT SERVICES
5.3.9 OTHERS
6 ASIA PACIFIC DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USERS
6.1 OVERVIEW
6.2 PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRIES
6.3 CONTRACT RESEARCH ORGANIZATIONS (CROS)
6.4 HOSPITALS
6.5 KPOS/BPOS
6.6 HEALTHCARE PROVIDERS
6.7 OTHERS
7 ASIA PACIFIC DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL
7.1 OVERVIEW
7.2 DIRECT SALES
7.3 RETAIL SALES
8 ASIA PACIFIC DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY GEOGRAPHY
8.1 ASIA-PACIFIC
8.1.1 CHINA
8.1.2 JAPAN
8.1.3 SOUTH KOREA
8.1.4 INDIA
8.1.5 AUSTRALIA
8.1.6 SINGAPORE
8.1.7 THAILAND
8.1.8 MALAYSIA
8.1.9 INDONESIA
8.1.10 PHILIPPINES
8.1.11 VIETNAM
8.1.12 REST OF ASIA-PACIFIC
9 ASIA PACIFIC DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, COMPANY LANDSCAPE
9.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
10 COMPANY PROFILE
10.1 SYNEOS HEALTH
10.1.1 COMPANY SNAPSHOT
10.1.2 REVENUE ANALYSIS
10.1.3 COMPANY SHARE ANALYSIS
10.1.4 SOLUTION PORTFOLIO
10.1.5 RECENT DEVELOPMENT
10.2 COVANCE INC. (A SUBSIDIARY OF LABCORP)
10.2.1 COMPANY SNAPSHOT
10.2.2 REVENUE ANALYSIS
10.2.3 COMPANY SHARE ANALYSIS
10.2.4 SERVICE PORTFOLIO
10.2.5 RECENT DEVELOPMENTS
10.3 COGNIZANT
10.3.1 COMPANY SNAPSHOT
10.3.2 REVENUE ANALYSIS
10.3.3 COMPANY SHARE ANALYSIS
10.3.4 SOLUTION PORTFOLIO
10.3.5 RECENT DEVELOPMENT
10.4 ACCENTURE
10.4.1 COMPANY SNAPSHOT
10.4.2 REVENUE ANALYSIS
10.4.3 COMPANY SHARE ANALYSIS
10.4.4 SERVICE PORTFOLIO
10.4.5 RECENT DEVELOPMENTS
10.5 PAREXEL INTERNATIONAL CORPORATION
10.5.1 COMPANY SNAPSHOT
10.5.2 PRODUCT PORTFOLIO
10.5.3 RECENT DEVELOPMENTS
10.6 ORACLE
10.6.1 COMPANY SNAPSHOT
10.6.2 REVENUE ANALYSIS
10.6.3 SOLUTION PORTFOLIO
10.6.4 RECENT DEVELOPMENT
10.7 AB CUBE
10.7.1 COMPANY SNAPSHOT
10.7.2 SOLUTION PORTFOLIO
10.7.3 RECENT DEVELOPMENT
10.8 ARISASIA PACIFIC
10.8.1 COMPANY SNAPSHOT
10.8.2 PRODUCT PORTFOLIO
10.8.3 RECENT DEVELOPMENTS
10.9 BIOCLINICA
10.9.1 COMPANY SNAPSHOT
10.9.2 SERVICE PORTFOLIO
10.9.3 RECENT DEVELOPMENTS
10.10 C3I
10.10.1 COMPANY SNAPSHOT
10.10.2 REVENUE ANALYSIS
10.10.3 SERVICE PORTFOLIO
10.10.4 RECENT DEVELOPMENTS
10.11 DRUG SAFETY SOLUTIONS LIMITED
10.11.1 COMPANY SNAPSHOT
10.11.2 SERVICE PORTFOLIO
10.11.3 RECENT DEVELOPMENT
10.12 ENNOV
10.12.1 COMPANY SNAPSHOT
10.12.2 PRODUCT PORTFOLIO
10.12.3 RECENT DEVELOPMENTS
10.13 ERGOMED PLC
10.13.1 COMPANY SNAPSHOT
10.13.2 REVENUE ANALYSIS
10.13.3 SERVICE PORTFOLIO
10.13.4 RECENT DEVELOPMENTS
10.14 GENPACT
10.14.1 COMPANY SNAPSHOT
10.14.2 REVENUE ANALYSIS
10.14.3 PRODUCT PORTFOLIO
10.14.4 RECENT DEVELOPMENTS
10.15 ICON PLC
10.15.1 COMPANY SNAPSHOT
10.15.2 REVENUE ANALYSIS
10.15.3 SERVICE PORTFOLIO
10.15.4 RECENT DEVELOPMENTS
10.16 IQVIA
10.16.1 COMPANY SNAPSHOT
10.16.2 REVENUE ANALYSIS
10.16.3 SOLUTION PORTFOLIO
10.16.4 RECENT DEVELOPMENTS
10.17 PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC.
10.17.1 COMPANY SNAPSHOT
10.17.2 SERVICE PORTFOLIO
10.17.3 RECENT DEVELOPMENTS
10.18 PHARMACEUTICAL RESEARCH ASSOCIATES INC.
10.18.1 COMPANY SNAPSHOT
10.18.2 REVENUE ANALYSIS
10.18.3 SOLUTION PORTFOLIO
10.18.4 RECENT DEVELOPMENTS
10.19 UNITED BIOSOURCE LLC
10.19.1 COMPANY SNAPSHOT
10.19.2 SERVICE PORTFOLIO
10.19.3 RECENT DEVELOPMENT
10.20 WORLDWIDE CLINICAL TRIALS
10.20.1 COMPANY SNAPSHOT
10.20.2 SERVICE PORTFOLIO
10.20.3 RECENT DEVELOPMENTS
11 QUESTIONNAIRE
12 RELATED REPORTS
UU
TABLE 1 CLINICAL TRIAL CONDUCTED IN DIFFERENT LOCATIONS
TABLE 2 TOP 20 PHARMA COMPANIES BY SIZE OF PIPELINE
TABLE 3 ASIA PACIFIC DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 4 ASIA PACIFIC SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 5 ASIA PACIFIC DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 6 ASIA PACIFIC ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 7 ASIA PACIFIC ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 8 ASIA PACIFIC DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 9 ASIA PACIFIC DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 10 ASIA PACIFIC DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 11 ASIA PACIFIC DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 12 ASIA PACIFIC FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 13 ASIA PACIFIC FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 14 ASIA PACIFIC ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 15 ASIA PACIFIC ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 16 ASIA PACIFIC CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 17 ASIA PACIFIC CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 18 ASIA PACIFIC REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 19 ASIA PACIFIC REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 20 ASIA PACIFIC MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 21 ASIA PACIFIC MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 22 ASIA PACIFIC OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 23 ASIA PACIFIC OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 24 ASIA PACIFIC SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 25 ASIA PACIFIC DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 26 ASIA PACIFIC CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 27 ASIA PACIFIC DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 28 ASIA PACIFIC REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 29 ASIA PACIFIC DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE, BY END USER, 2017-2026 (USD MILLION)
TABLE 30 ASIA PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 31 ASIA PACIFIC CONTRACT RESEARCH ORGANIZATIONS (CROS) IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 32 ASIA PACIFIC HOSPITALS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 33 ASIA PACIFIC KPOS/BPOS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 34 ASIA PACIFIC HEALTHCARE PROVIDERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 35 ASIA PACIFIC OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 36 ASIA PACIFIC DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 37 ASIA PACIFIC DIRECT SALES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 38 ASIA PACIFIC RETAIL SALES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 39 ASIA-PACIFIC DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 40 ASIA-PACIFIC DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 41 ASIA-PACIFIC DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 42 ASIA-PACIFIC ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 43 ASIA-PACIFIC DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 44 ASIA-PACIFIC DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 45 ASIA-PACIFIC FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 46 ASIA-PACIFIC ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 47 ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 48 ASIA-PACIFIC REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 49 ASIA-PACIFIC MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 50 ASIA-PACIFIC OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 51 ASIA-PACIFIC DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 52 ASIA-PACIFIC CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 53 ASIA-PACIFIC DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 54 ASIA-PACIFIC REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 55 ASIA-PACIFIC DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 56 ASIA-PACIFIC DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 57 CHINA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 58 CHINA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 59 CHINA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 60 CHINA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 61 CHINA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 62 CHINA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 63 CHINA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 64 CHINA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 65 CHINA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 66 CHINA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 67 CHINA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 68 CHINA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 69 CHINA CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 70 CHINA DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 71 CHINA REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 72 CHINA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 73 CHINA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 74 JAPAN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 75 JAPAN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 76 JAPAN ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 77 JAPAN DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 78 JAPAN DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 79 JAPAN FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 80 JAPAN ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 81 JAPAN CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 82 JAPAN REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 83 JAPAN MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 84 JAPAN OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 85 JAPAN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 86 JAPAN CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 87 JAPAN DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 88 JAPAN REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 89 JAPAN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 90 JAPAN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 91 SOUTH KOREA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 92 SOUTH KOREA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 93 SOUTH KOREA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 94 SOUTH KOREA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 95 SOUTH KOREA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 96 SOUTH KOREA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 97 SOUTH KOREA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 98 SOUTH KOREA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 99 SOUTH KOREA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 100 SOUTH KOREA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 101 SOUTH KOREA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 102 SOUTH KOREA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 103 SOUTH KOREA CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 104 SOUTH KOREA DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 105 SOUTH KOREA REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 106 SOUTH KOREA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 107 SOUTH KOREA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 108 INDIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 109 INDIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 110 INDIA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 111 INDIA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 112 INDIA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 113 INDIA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 114 INDIA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 115 INDIA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 116 INDIA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 117 INDIA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 118 INDIA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 119 INDIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 120 INDIA CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 121 INDIA DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 122 INDIA REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 123 INDIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 124 INDIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 125 AUSTRALIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 126 AUSTRALIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 127 AUSTRALIA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 128 AUSTRALIA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 129 AUSTRALIA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 130 AUSTRALIA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 131 AUSTRALIA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 132 AUSTRALIA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 133 AUSTRALIA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 134 AUSTRALIA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 135 AUSTRALIA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 136 AUSTRALIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 137 AUSTRALIA CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 138 AUSTRALIA DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 139 AUSTRALIA REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 140 AUSTRALIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 141 AUSTRALIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 142 SINGAPORE DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 143 SINGAPORE DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 144 SINGAPORE ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 145 SINGAPORE DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 146 SINGAPORE DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 147 SINGAPORE FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 148 SINGAPORE ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 149 SINGAPORE CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 150 SINGAPORE REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 151 SINGAPORE MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 152 SINGAPORE OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 153 SINGAPORE DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 154 SINGAPORE CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 155 SINGAPORE DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 156 SINGAPORE REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 157 SINGAPORE DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 158 SINGAPORE DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 159 THAILAND DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 160 THAILAND DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 161 THAILAND ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 162 THAILAND DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 163 THAILAND DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 164 THAILAND FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 165 THAILAND ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 166 THAILAND CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 167 THAILAND REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 168 THAILAND MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 169 THAILAND OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 170 THAILAND DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 171 THAILAND CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 172 THAILAND DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 173 THAILAND REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 174 THAILAND DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 175 THAILAND DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 176 MALAYSIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 177 MALAYSIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 178 MALAYSIA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 179 MALAYSIA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 180 MALAYSIA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 181 MALAYSIA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 182 MALAYSIA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 183 MALAYSIA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 184 MALAYSIA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 185 MALAYSIA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 186 MALAYSIA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 187 MALAYSIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 188 MALAYSIA CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 189 MALAYSIA DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 190 MALAYSIA REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 191 MALAYSIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 192 MALAYSIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 193 INDONESIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 194 INDONESIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 195 INDONESIA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 196 INDONESIA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 197 INDONESIA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 198 INDONESIA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 199 INDONESIA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 200 INDONESIA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 201 INDONESIA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 202 INDONESIA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 203 INDONESIA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 204 INDONESIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 205 INDONESIA CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 206 INDONESIA DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 207 INDONESIA REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 208 INDONESIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 209 INDONESIA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 210 PHILIPPINES DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 211 PHILIPPINES DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 212 PHILIPPINES ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 213 PHILIPPINES DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 214 PHILIPPINES DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 215 PHILIPPINES FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 216 PHILIPPINES ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 217 PHILIPPINES CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 218 PHILIPPINES REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 219 PHILIPPINES MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 220 PHILIPPINES OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 221 PHILIPPINES DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 222 PHILIPPINES CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 223 PHILIPPINES DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 224 PHILIPPINES REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 225 PHILIPPINES DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 226 PHILIPPINES DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 227 VIETNAM DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 228 VIETNAM DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 229 VIETNAM ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 230 VIETNAM DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 231 VIETNAM DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 232 VIETNAM FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 233 VIETNAM ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 234 VIETNAM CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 235 VIETNAM REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 236 VIETNAM MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 237 VIETNAM OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)
TABLE 238 VIETNAM DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 239 VIETNAM CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 240 VIETNAM DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 241 VIETNAM REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)
TABLE 242 VIETNAM DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 243 VIETNAM DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 244 REST OF ASIA-PACIFIC DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...